There is a newer version of this record available.

Dataset Open Access

The process of HDAC11 Assay Development: time-course study follow-up

Abbey, Megha; Vedadi, Masoud

The time of incubation and conc. of the developer to be used are important parameters during HDAC11 assay optimization and thus, have been considered here.

The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files (174.5 kB)
Name Size
27april2018-HDAC11 assay deve process-time course followup.pdf
174.5 kB Download
All versions This version
Views 12768
Downloads 7122
Data volume 11.5 MB3.8 MB
Unique views 9057
Unique downloads 3821


Cite as